Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-19-002005

President and CEO sold 15,000 shares at an average $58.53 ($877,989)

  • President and CEO acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mills Kenneth T. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-19 Exercise or conversion : show line 1 in the form +15,000 $0.85 $12,750 261,000 D
2019-03-19 Sale : show line 2 in the form −5,870 $58.21 $341,693 255,130 D
2019-03-19 Sale : show line 3 in the form −9,130 $58.74 $536,296 246,000 D
Open-market sales · 15,000 sh · avg $58.53 · $877,989

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-19 Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) −15,000 $0.85 2024-09-23 15,000 159,670 D
Loading xslF345X03/primarydocument.xml…